A Study to Evaluate the Feasibility and Safety of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation
Sponsor: |
Boston Scientific Corporation |
Enrolling: |
Male and Female Patients |
Clinic Visits: |
8 |
IRB Number: |
AAAT5421 |
U.S. Govt. ID: |
NCT04147884 |
Contact: |
Kate Dalton: 347-514-3366 / keb2114@cumc.columbia.edu |
The Millipede Feasibility Study is a prospective, open-label, single-arm study to assess the safety and feasibility of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation. The Millipede Annuloplasty Ring System is a novel transcatheter, fully adjustable, complete annuloplasty repair device for the treatment of mitral regurgitation. The device is designed to mimic a widely used surgical intervention with a percutaneous therapy. As such, it potentially offers a less invasive and safer treatment for mitral regurgitation in comparison to surgery. The purpose of this study is to evaluate the feasibility and safety of the Millipede Annuloplasty Ring System in patients with functional mitral regurgitation
This study is closed
Investigator
Susheel Kodali, MD
Are you 18 years of age or older? |
Yes |
No |
Have you had a prior closure of an Atrial septal defect (ASD) or patent formane ovale (PFO)? |
Yes |
No |
Do you have COPD requiring continuous oxygen use? |
Yes |
No |